Increased bcl-2 protein levels in rat primary astrocyte culture following chronic lithium treatment

Iranian Journal of Medical Sciences

Volumn 38, Issue 3, 2013, Pages 255-262

  Keshavarz, Mojtaba ^a   Emamghoreishi, Masoumeh ^a   Nekooeian, Ali Akbar ^a   Warsh, Jerry J ^b   Zare, Hamid Reza ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

Astrocytes; bcl 2; Lithium; Neuron; Primary cell culture

Indexed keywords

LITHIUM CHLORIDE; MESSENGER RNA; PROTEIN BCL 2;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BCL 2 GENE; CHRONIC DRUG ADMINISTRATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG TARGETING; EMBRYO; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE; GENE EXPRESSION REGULATION; IMMUNOCYTOCHEMISTRY; NERVE CELL CULTURE; NONHUMAN; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION;

EID: 84883303250     PISSN: 02530716     EISSN: 17353688     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Chuang DM. The antiapoptotic actions of mood stabilizers: molecular mechanisms and therapeutic potentials. Ann N Y Acad Sci. 2005;1053:195-204. doi: 10.1196/ annals.1344.018. PubMed PMID: 16179524.
2. Chen G, Zeng WZ, Yuan PX, Huang LD, Jiang YM, Zhao ZH, et al. The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS. J Neurochem. 1999;72:879-82. PubMed PMID: 9930766.
3. Kim HW, Rapoport SI, Rao JS. Altered expression of apoptotic factors and synaptic markers in postmortem brain from bipolar disorder patients. Neurobiol Dis. 2010;37: 596-603. doi: 10.1016/j.nbd.2009.11.010. PubMed PMID: 19945534; PubMed Central PMCID: PMC2823851.
4. Manji HK, Chen G. PKC, MAP kinases and the bcl-2 family of proteins as long-term targets for mood stabilizers. Mol Psychiatry. 2002;7:S46-56. doi: 10.1038/sj.mp. 4001018. PubMed PMID: 11986995.
5. Lien R, Flaisher-Grinberg S, Cleary C, Hejny M, Einat H. Behavioral effects of Bcl-2 defciency: implications for affective disorders. Pharmacol Rep. 2008;60:490-8. PubMed PM I D: 1879 9 817.
6. Salvadore G, Nugent AC, Chen G, Akula N, Yuan P, Cannon DM, et al. Bcl-2 polymorphism infuences gray matter volume in the ventral striatum in healthy humans. Biol Psychiatry. 2009;66:804-7. doi: 10.1016/j.biopsych.2009.05.025. PubMed PMID: 19589501; PubMed Central PMCID: PMC2788985.
7. Drevets WC, Price JL, Furey ML. Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Struct Funct. 2008;213:93-118. doi: 10.1007/s00429-008-0189-x. PubMed PMID: 18704495; PubMed Central PMCID: PMC2522333.
8. Savitz J, Drevets WC. Bipolar and major depressive disorder: neuroimaging the developmental-degenerative divide. Neurosci Biobehav Rev. 2009;33:699-771. doi: 10.1016/j.neubiorev.2009.01.004. PubMed PMID: 19428491; PubMed Central PMCID: PMC2858318.
9. Lyoo IK, Dager SR, Kim JE, Yoon SJ, Friedman SD, Dunner DL, et al. Lithium-induced gray matter volume increase as a neural correlate of treatment response in bipolar disorder: a longitudinal brain imaging study. Neuropsychopharmacology. 2010;35:1743-50. doi: 10.1038/npp.2010.41. PubMed PMID: 20357761; PubMed Central PMCID: PMC3055479.
10. Chang YC, Rapoport SI, Rao JS. Chronic administration of mood stabilizers upregulates BDNF and bcl-2 expression levels in rat frontal cortex. Neurochem Res. 2009;34:536-41. doi: 10.1007/s11064-008-9817-3. PubMed PMID: 18719996; PubMed Central PMCID: PMC2637936.
11. Chen G, Masana MI, Manji HK. Lithium regulates PKC-mediated intracellular crosstalk and gene expression in the CNS in vivo. Bipolar Disord. 2000;2:217-36. doi: 10.1034/j.1399-5618.2000.20303.x. PubMed P M I D: 11249 8 0 0.
12. Trendelenburg G, Dirnagl U. Neuroprotective role of astrocytes in cerebral ischemia: focus on ischemic preconditioning. Glia. 2005;50:307-20. doi: 10.1002/glia.20204. PubMed PMID: 15846804.
13. Pellerin L, Magistretti PJ. How to balance the brain energy budget while spending glucose differently. J Physiol. 2003;546:325. doi: 10.1113/jphysiol.2002.035105. PubMed PMID: 12527720; PubMed Central PMCID: PMC2342533.
14. Xu L, Lee JE, Giffard RG. Overexpression of bcl-2, bcl-XL or hsp70 in murine cortical astrocytes reduces injury of co-cultured neurons. Neurosci Lett. 1999;277:193-7. doi: 10.1016/S0304-3940(99)00882-4. PubMed PMID: 10626846.
15. Rosenberg PA, Aizenman E. Hundred-fold increase in neuronal vulnerability to glutamate toxicity in astrocyte-poor cultures of rat cerebral cortex. Neurosci Lett. 1989;103:162-8. doi: 10.1016/0304-3940(89)90569-7. PubMed PMID: 2570387.
16. Ongür D, Drevets WC, Price JL. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci U S A. 1998;95:13290-5. doi: 10.1073/ pnas.95.22.13290. PubMed PMID: 9789081; PubMed Central PMCID: PMC23786.
17. Bowley MP, Drevets WC, Ongür D, Price JL. Low glial numbers in the amygdala in major depressive disorder. Biol Psychiatry. 2002;52:404-12. doi: 10.1016/S0006-3223(02)01404-X. PubMed PMID: 12242056.
18. Cole R, Vellis J. Preparation of Astrocyte, Oligodendrocyte, and Microglia Cultures from Primary Rat Cerebral Cultures. In: Fedoroff S, Richardson A. Protocols for Neural Cell Culture. Humana Press; 2001. p. 117-27.
19. Feeney CJ, Frantseva MV, Carlen PL, Pennefather PS, Shulyakova N, Shniffer C, et al. Vulnerability of glial cells to hydrogen peroxide in cultured hippocampal slices. Brain Res. 2008;1198:1-15. doi: 10.1016/j. brainres.2007.12.049. PubMed PMID: 182 61717.
20. Liu B, Hong JS. Primary rat mesencephalic neuron-glia, neuron-enriched, microglia-enriched, and astroglia-enriched cultures. Methods Mol Med. 2003;79:387-95. doi: 10.1385/1-59259-358-5:387. PubMed PMID: 12506711.
21. Chamak B, Fellous A, Glowinski J, Prochiantz A. MAP2 expression and neuritic outgrowth and branching are coregulated through region-specifc neuro-astroglial interactions. J Neurosci. 1987;7:3163-70. PubMed PMID: 2444676.
22. Mc Lendon RE, Bigner DD. Immunohistochemistry of the glial fbrillary acidic protein: basic and applied considerations. Brain Pathol. 19 9 4;4: 2 21- 8. d o i: 10.1111/ j.175 0 - 3 6 3 9.19 9 4. tb00837.x. PubMed PMID: 7952263.
23. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-9. doi: 10.1006/ abio.1987.9999. PubMed PMID: 2440339.
24. Kruger NJ. The Bradford Method for Protein Quantitation. In: Walker JM. The Protein Protocols Handbook. Humana Press; 2002. p. 15-21.
25. Pfaff MW, Horgan GW, Dempfe L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 2002;30:e36. doi: 10.1093/ nar/30.9.e36. PubMed PMID: 11972351; PubMed Central PMCID: PMC113859.
26. Corson TW, Woo KK, Li PP, Warsh JJ. Cell-type specifc regulation of calreticulin and Bcl-2 expression by mood stabilizer drugs. Eur Neuropsychopharmacol. 2004;14:143-50. doi: 10.1016/S0924-977X(03)00102-0. PubMed PMID: 15013030.
27. Lai JS, Zhao C, Warsh JJ, Li PP. Cytoprotection by lithium and valproate varies between cell types and cellular stresses. Eur J Pharmacol. 2006;539:18-26. PubMed PMID: 16678157.
28. Jacobsen JP, Mørk A. The effect of escitalopram, desipramine, electroconvulsive seizures and lithium on brain-derived neurotrophic factor mRNA and protein expression in the rat brain and the correlation to 5-HT and 5-HIAA levels. Brain Res. 2004;1024:183-92. doi: 10.1016/j. brainres.2004.07.065. PubMed PMID: 15 451381.
29. Atwater JA, Wisdom R, Verma IM. Regulated mRNA stability. Annu Rev Genet. 1990;24:519-41. doi: 10.1146/annurev.ge.24.120190.002511. PubMed PMID: 2088178.
30. Shim M, Smart RC. Lithium stabilizes the CCAAT/enhancer-binding protein alpha (C/ EBPalpha) through a glycogen synthase kinase 3 (GSK3)-independent pathway involving direct inhibition of proteasomal activity. J Biol Chem. 2003;278:19674-81. doi: 10.1074/jbc.M301356200. PubMed PMID: 12668682.
31. Hammonds MD, Shim SS, Feng P, Calabrese JR. Effects of subchronic lithium treatment on levels of BDNF, Bcl-2 and phospho-CREB in the rat hippocampus. Basic Clin Pharmacol Toxicol. 2007;100:356-9. doi: 10.1111/ j.1742 78 4 3. 2 0 07. 0 0 0 5 8 x. P u b M e d PMID: 174 48124.
32. Hiroi T, Wei H, Hough C, Leeds P, Chuang DM. Protracted lithium treatment protects against the ER stress elicited by thapsigargin in rat PC12 cells: roles of intracellular calcium, GRP78 and Bcl-2. Pharmacogenomics J. 2005;5:102-11. doi: 10.1038/sj.tpj.6500296. PubMed PMID: 15668729.
33. Chen RW, Chuang DM. Long term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression. A prominent role in neuroprotection against excitotoxicity. J Biol Chem. 1999;274:6039-42. doi: 10.1074/ jbc.274.10.6039. PubMed PMID: 10037682.
34. Chen G, Rajkowska G, Du F, Seraji-Bozorgzad N, Manji HK. Enhancement of hippocampal neurogenesis by lithium. J Neurochem. 2000;75:1729-34. doi: 10.1046/j.1471-4159.2000.0751729.x. PubMed PMID: 10987856.
35. Song N, Boku S, Nakagawa S, Kato A, Toda H, Takamura N, et al. Mood stabilizers commonly restore staurosporine-induced increase of p53 expression and following decrease of Bcl-2 expression in SH-SY5Y cells. Prog Neuropsychopharmacol Biol Psychiatry. 2012;38:183-9. doi: 10.1016/j. pnpbp.2012.03.006. PubMed PMID: 22484386.
36. Adler CM, Levine AD, DelBello MP, Strakowski SM. Changes in gray matter volume in patients with bipolar disorder. Biol Psychiatry. 2005;58:151-7. doi: 10.1016/j. biopsych.2005.03.022. PubMed PMID: 15922309.
37. Hajek T, Carrey N, Alda M. Neuroanatomical abnormalities as risk factors for bipolar disorder. Bipolar Disord. 2005;7:393-403. doi: 10.1111/ j.13 9 9 - 5 618. 2 0 0 5.0 0 2 3 8. x. Pu b M e d PMID: 16176432.
38. Rajkowska G, Halaris A, Selemon LD. Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder. Biol Psychiatry. 2001;49:741-52. doi: 10.1016/S0006-3223(01)01080-0. PubMed PMID: 11331082.
39. Sanchez JF, Sniderhan LF, Williamson AL, Fan S, Chakraborty-Sett S, Maggirwar SB. Glycogen synthase kinase 3beta-mediated apoptosis of primary cortical astrocytes involves inhibition of nuclear factor kappaB signaling. Mol Cell Biol. 2003;23:4649-62. doi: 10.1128/mcb.23.13.4649-4662.2003. PubMed PMID: 12808104; PubMed Central PMCID: PMC164840.
40. Manji HK, Moore GJ, Chen G. Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: a role for neurotrophic and neuroprotective effects in manic depressive illness. J Clin Psychiatry. 2000;61:82-96. PubMed PMID: 10826666.